Initiative Aims to Limit Excessive Red Tape for African Science

Research organizations and universities have typically faced burdensome paperwork to convince funders their money would not be wasted.

Written byMunyaradzi Makoni
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: At the Science Forum South Africa on December 12, 2018, organizers unveiled the Good Financial Grant Practice (GFGP). Pictured in the front row (left to right) are grant recipients who have trialled the GFGP, followed by Tom Kariuki, the director of programs at the Alliance for Accelerating Excellence in Science in Africa at the African Academy of Sciences, Nelson Torto, the executive director of the African Academy of Sciences, Michael Kilpatrick, senior advisor to GFGP, Raymond Murenzi, director Rwanda Standards Board, and Berhanu Abegaz, former executive director of the African Academy of Sciences.
FLICKR, AFRICAN ACADEMY OF SCIENCES

For every grant his university won, Robin Drennan had to perform due diligence exercises—responding to a dozen queries from worried funders and certifying that the grant money won’t go to waste before it was released.

“In practice, it’s answering 500 questions,” he says. “Do you have a policy on corruption? Do you ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • munya makoni

    Munyaradzi is a freelance journalist based in Cape Town, South Africa. He covers agriculture, climate change, environment, health, higher education, sustainable development, and science in general. Among other outlets, his work has appeared in Hakai magazine, Nature, Physics World, Science, SciDev.net, The Lancet, The Scientist, Thomson Reuters Foundation, and University World News.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies